← Back to Clinical Trials
Recruiting NCT05997381

BioBrace® Implant for Arthroscopic Repair of Full Thickness Rotator Cuff Tears

Trial Parameters

Condition Rotator Cuff Tears
Sponsor CONMED Corporation
Study Type INTERVENTIONAL
Phase N/A
Enrollment 268
Sex ALL
Min Age 40 Years
Max Age 70 Years
Start Date 2024-01-05
Completion 2026-12
Interventions
Arthroscopic rotator cuff repair with BioBrace® Implant augmentation.Arthroscopic rotator cuff repair

Brief Summary

This study aims to evaluate the safety and effectiveness of arthroscopic rotator cuff repair augmented with the BioBrace® Implant vs. arthroscopic rotator cuff repair alone in subjects requiring surgical intervention for a full-thickness rotator cuff tear.

Eligibility Criteria

Inclusion Criteria: 1. Male or female 40 to 70 years old 2. Positive diagnostic imaging by MRI within 6 months of enrollment of the index shoulder indicating a full thickness rotator cuff tear (RCT): 1. Tear of the supraspinatus and/or infraspinatus tendons 2. Tear size ≥ 2 cm and \< 5 cm 3. Chronic shoulder pain ≥ 3 months 4. Failed non-operative treatment of the index shoulder to include one or all of the following: 1. Oral analgesics 2. Nonsteroidal anti-inflammatory medications (NSAIDs) 3. Corticosteroid injections 4. Activity modifications 5. Physical therapy or home-guided exercises 5. Able to read and understand the study REB/IRB approved Informed Consent Form (ICF) 6. Willing to be available to attend each protocol-required follow-up examination Intraoperative Inclusion Criteria: 1. Full thickness tear of the supraspinatus and/or infraspinatus tendons 2. Tear size ≥ 2 cm and \< 5 cm 3. Able to reapproximate the tendons to cover \> 50% of the footprint on the greater tuberosity

Related Trials